OSBPL7-IN-1 is an orally bioavailable small molecule inhibitor of OSBPL7. It enhances ABCA1 localization to the plasma membrane post-transcriptionally, making it a useful research tool for studying cholesterol transport and atherosclerosis-related pathways in cellular and animal models.